RB
Ron Baron (Baron Capital) disclosed increased in VERTEX PHARMACEUTICALS INC
Ron Baron (Baron Capital) filed a 13F change in VERTEX PHARMACEUTICALS INC (92532F100) on 2026-05-15, covering period end 2026-03-31.
Action
Increased
Capital
$991,578 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.